Clinical Professor Stephanie Watson

NHMRC Career Development Fellow and Clinical Professor
Clinical Ophthalmology & Eye Health, Central Clinical School
Save Sight Institute

T: 9389 0666
F: 93890122

Biographical details

Dr Watson is a specialist in corneal surgery at the Sydney Eye Hospital, Sydney Children's and Prince of Wales Hospital. She completed sub-speciality training at Moorfields Eye Hospital, London and was awarded a PhD for the development of a new dry eye therapy. She is a Clincal Professor in the Sydney University Medical School, a conjoint senior lecturer at the University of New South Wales, a Director of the Ophthalmic Research Institute of Australia and Editor for the Cochrane Eyes and Vision Group. She has been supported by an NHMRC Fellowship, Fight for Sight Bursary, Moorfields Eye Hospital Special Trustees, Eye Bank Association of America, Alcon-RANZCO Scholarship, RANZCO-John Parr Scholarship, and the Tear Film and Ocular Surface Society Young Investigator award. Her stem cell research has been featured in the international, national and local news. She was invited to appear on the ‘New Inventors’ programme on the ABC and was the episode and people’s choice award winner. In addition, she was awarded the 'Les is more' grand final award. Recently, her stem cell work was featured on the ABC programme, Catalyst and in the Qantas inflight magazine.

Research interests

Dr Watson has developed new techniques for stem cell therapy and corneal surgery, which have been presented at international meetings and published in high impact (A*) peer-reviewed journals. Dr Watson has also investigated and published on corneal wound healing and corneal infection. Dr Watson has completed 7 clinical trials and 5 clinical audits. She has extensive experience in in vitro and in vivo corneal models having developed a wound healing model during her PhD. Dr Watson is a CI on an NHMRC project grant for sutureless surgery and an Australian Stem Cell Centre grant for her stem cell work. Dr Watson holds an international patent for Therapeutic Ocular Surface Medium, an novel therapy for dry eye and corneal ulcer.